Trxade Stock Analysis

MEDS -  USA Stock  

USD 4.45  0.19  4.09%

The latest price spike of Trxade Health may encourage retail investors to take a closer look at the company as it is trading at a share price of 4.45 on 159,852 in trading volume. The company directors and management may have good odds in positioning the company resources to exploit market volatility in July. The stock standard deviation of daily returns for 90 days investing horizon is currently 18.21. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Trxade Health partners.
Additionally, see Stocks Correlation.

Search Stock Analysis 

 
Refresh
The Trxade Health stock analysis report makes it easy to digest most publicly released information about Trxade Health and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Trxade stock analysis module also helps to analyze the Trxade Health price relationship with some important fundamental indicators such as market cap and management efficiency.

Trxade Stock Analysis Notes

About 62.0% of the company outstanding shares are owned by corporate insiders. The book value of Trxade Health was now reported as 0.75. The company recorded a loss per share of 0.07. Trxade Health had not issued any dividends in recent years. The entity had 1-6 split on the 11th of August 2008. Trxade Group, Inc., together with its subsidiaries, operates a business-to-business web-based marketplace focused on the pharmaceutical industry in the United States. In addition, it operates Trxade Prime, which allows pharmacy members on the Trxade platform to process, consolidate, and ship purchase orders that are placed directly with Trxade suppliers Bonum Health Hub, a virtual examination room Bonum, a B2B platform to purchase COVID-19 risk assessment and personal protective equipment tools and MedCheks, a healthcare platform that lets patients consolidate and control their health data via a digital Health Passport and allows them to share their health profile, tests, and vaccination. Trxade Health operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 43 people. To find out more about Trxade Health contact the company at 800 261 0281 or learn more at http://www.trxadegroup.com.

Trxade Health Quarterly Cost of Revenue

1.67 MillionShare

Trxade Health Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Trxade Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Trxade Health or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Trxade Health is way too risky over 90 days horizon
Trxade Health appears to be risky and price may revert if volatility continues
Trxade Health was previously known as TRxADE HEALTH INC and was traded on NASDAQ Exchange under the symbol TRXD.
The company reported the previous year's revenue of 17.97 M. Net Loss for the year was (3.37 M) with profit before overhead, payroll, taxes, and interest of 5.71 M.
Trxade Health currently holds about 5.21 M in cash with (2.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64.
Roughly 62.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.nasdaq.com: Shareholders Are Thrilled That The TRxADE HEALTH Share Price Increased 178 percent - Nasdaq

Trxade Largest EPS Surprises

Earnings surprises can significantly impact Trxade Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-10-26
2020-09-300.030.02-0.0133 
2020-05-04
2020-03-310.010.020.01100 
2015-07-30
2015-06-30-0.06-0.01040.049682 
View All Earnings Estimates

Trxade Health SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Trxade Health prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Trxade Health investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Trxade Health specific information freely available to individual and institutional investors to make a timely investment decision.
28th of May 2021
Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets
View
19th of May 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
26th of April 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
21st of April 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
29th of March 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
3rd of March 2021
Other Events. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
1st of March 2021
Financial Statements and Exhibits. Regulation FD Disclosure
View
18th of November 2020
Financial Statements and Exhibits. Regulation FD Disclosure
View

Trxade Health Thematic Classifications

In addition to having Trxade Health stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Wholesale IdeaWholesale
USA Equities from Wholesale industry as classified by Fama & French

Trxade Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 42.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Trxade Health's market, we take the total number of its shares issued and multiply it by Trxade Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Trxade Profitablity

Trxade Health's profitability indicators refer to fundamental financial ratios that showcase Trxade Health's ability to generate income relative to its revenue or operating costs. If, let's say, Trxade Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Trxade Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Trxade Health's profitability requires more research than a typical breakdown of Trxade Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (18.74) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (14.54) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.15.
Last ReportedProjected for 2021
Return on Average Assets(0.23) (0.25) 
Return on Average Equity(0.26) (0.28) 
Return on Invested Capital(0.55) (0.59) 
Return on Sales(0.15) (0.16) 

Management Efficiency

The entity has return on total asset (ROA) of (15.43) % which means that it has lost $15.43 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (37.76) %, meaning that it created substantial loss on money invested by shareholders. Trxade Health management efficiency ratios could be used to measure how well trxade health manages its routine affairs as well as how well it operates its assets and liabilities. As of 06/17/2021, Return on Average Assets is likely to drop to -0.25. In addition to that, Return on Average Equity is likely to drop to -0.28. Trxade Health Total Assets are relatively stable at the moment as compared to the past year. Trxade Health reported last year Total Assets of 9.79 Million. As of 06/17/2021, Current Assets is likely to grow to about 9.9 M, while Goodwill and Intangible Assets are likely to drop slightly above 649.6 K.
Last ReportedProjected for 2021
Book Value per Share 1.13  1.21 
Enterprise Value over EBIT(13.50) (14.56) 
Enterprise Value over EBITDA(13.74) (14.82) 
Price to Book Value 4.44  4.41 
Tangible Assets Book Value per Share 1.27  1.37 
Enterprise Value33 M32.8 M
Tangible Asset Value9.8 M10.6 M

Technical Drivers

As of the 17th of June 2021, Trxade Health has the Coefficient Of Variation of 1582.62, semi deviation of 5.58, and Risk Adjusted Performance of 0.1164. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Trxade Health, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to break down nineteen technical drivers for Trxade Health, which can be compared to its competition. Please validate Trxade Health coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Trxade Health is priced more or less accurately, providing market reflects its prevalent price of 4.45 per share. Given that Trxade Health has jensen alpha of 1.14, we advise you to double-check Trxade Health's current market performance to make sure the company can sustain itself at a future point.

Trxade Health Price Movement Analysis

The output start index for this execution was nine with a total number of output elements of four hundred fifty-seven. The Exponential Moving Average is calculated by weighting recent values of Trxade Health more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Trxade Health Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Trxade Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Trxade Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Trxade Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Trxade Health Predictive Daily Indicators

Trxade Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Trxade Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Trxade Health Forecast Models

Trxade Health time-series forecasting models is one of many Trxade Health's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Trxade Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Trxade Health Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Trxade Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Trxade shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Trxade Health. By using and applying Trxade Stock analysis, traders can create a robust methodology for identifying Trxade entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(0.14) (0.15) 
Gross Margin 0.33  0.34 
Profit Margin(0.15) (0.16) 
Trxade Group, Inc., together with its subsidiaries, operates a business-to-business web-based marketplace focused on the pharmaceutical industry in the United States. In addition, it operates Trxade Prime, which allows pharmacy members on the Trxade platform to process, consolidate, and ship purchase orders that are placed directly with Trxade suppliers Bonum Health Hub, a virtual examination room Bonum, a B2B platform to purchase COVID-19 risk assessment and personal protective equipment tools and MedCheks, a healthcare platform that lets patients consolidate and control their health data via a digital Health Passport and allows them to share their health profile, tests, and vaccination. Trxade Health operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.

Current Trxade Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Trxade analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Trxade analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
10.69Buy4Odds
Trxade Health current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Trxade analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Trxade stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Trxade Health, talking to its executives and customers, or listening to Trxade conference calls.
Trxade Analyst Advice Details

Trxade Stock Analysis Indicators

Trxade Health stock analysis indicators help investors evaluate how Trxade Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Trxade Health shares will generate the highest return on investment. By understating and applying Trxade Health stock analysis, traders can identify Trxade Health position entry and exit signals to maximize returns.
Quick Ratio6.65
Fifty Two Week Low3.10
Revenue Growth38.60%
Shares Short Prior Month5.45k
Average Daily Volume Last 10 Day24.44M
Average Daily Volume In Three Month3.12M
Shares Percent Shares Out0.32%
Gross Margins30.33%
Short Percent Of Float0.70%
Forward Price Earnings13.66
Float Shares3.28M
Fifty Two Week High10.82
Enterprise Value To Ebitda-10.79
Fifty Day Average3.87
Two Hundred Day Average5.34
Enterprise Value To Revenue1.57
Additionally, see Stocks Correlation. Note that the Trxade Health information on this page should be used as a complementary analysis to other Trxade Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Trxade Health Stock analysis

When running Trxade Health stock analysis, check to measure Trxade Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trxade Health is operating at the current time. Most of Trxade Health's stock examination focuses on studying past and present price action to predict the probability of Trxade Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Trxade Health's price. Additionally, you may evaluate how the addition of Trxade Health to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
The market value of Trxade Health is measured differently than its book value, which is the value of Trxade that is recorded on the company's balance sheet. Investors also form their own opinion of Trxade Health stock's value that differs from its market value or its book value, called intrinsic value, which is Trxade Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trxade Health's market value can be influenced by many factors that don't directly affect Trxade Health underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trxade Health's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Trxade Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trxade Health's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.